Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) Q4 2024 Annual Earnings

LXEO·Reported March 24, 2025·Before market open

Diluted EPS came in at $-0.78, beat the $-0.87 consensus by $0.09.

Diluted EPS
$-0.78beat by $0.09
Consensus: $-0.87
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0000950170-25-043486

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Lexeo Therapeutics, Inc.'s Q4 2024 earnings report.

Lexeo Therapeutics, Inc. (LXEO) reported Q4 2024 earnings on March 24, 2025 before market open.

Lexeo Therapeutics, Inc. reported diluted EPS of $-0.78 for Q4 2024.

EPS beat the consensus estimate of $-0.87 by $0.09.

You can read the 10-K periodic report (0000950170-25-043486) directly on SEC EDGAR. The filing index links above go to sec.gov.